Cutaneous Toxicities in Lung Cancer Patients on Immune Checkpoint Inhibitor Therapy
Author:
Funder
GlaxoSmithKline
University of Texas MD Anderson Cancer Center
Eli Lilly and Company
Publisher
Elsevier BV
Subject
Cancer Research,Pulmonary and Respiratory Medicine,Oncology
Reference22 articles.
1. Immune-related adverse events with immune checkpoint blockade: a comprehensive review;Michot;Eur J Cancer (Oxford, England: 1990),2016
2. Comparison of the toxicity profile of PD-1 versus PD-L1 inhibitors in non-small cell lung cancer: a systematic analysis of the literature;Pillai;Cancer,2018
3. Dermatologic complications of anti-PD-1/PD-L1 immune checkpoint antibodies;Sibaud;Curr Opin Oncol,2016
4. Immune checkpoint inhibitors in clinical practice: update on management of immune-related toxicities;Villadolid;Transl Lung Cancer Res,2015
5. Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer;Borghaei;New Engl J Med,2015
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Advancing non-small cell lung cancer treatment: the power of combination immunotherapies;Frontiers in Immunology;2024-07-02
2. Clinical Experience of External Application of Clearing Heat and Removing Dampness in Relieving Grade 2 to 3 Rash Caused by Programed Cell Death Protein 1 (PD-1)/Programed Cell Death Ligand 1 (PD-L1) Inhibitors: A Single-Center Retrospective Study;Integrative Cancer Therapies;2024-01
3. Acneiform eruption induced by molecularly targeted agents in antineoplastic therapy: A review;Journal of Cosmetic Dermatology;2023-03-16
4. Cutaneous adverse events in lung cancer patients on the therapy based on PD-1/PD-L1 inhibitors: A prospective observational cohort study;Current Problems in Cancer;2023-02
5. Expert guidance on prophylaxis and treatment of dermatologic adverse events with Tumor Treating Fields (TTFields) therapy in the thoracic region;Frontiers in Oncology;2023-01-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3